Back to Healthcare
Healthcare·Trending Solutions

Solutions advancing healthcare in the US & EU

Healthcare IT is at an inflection point — FHIR mandates, AI medical devices, and cross-border data spaces are reshaping how care is delivered. Here are the solutions trending now.

$394 B
US HealthTech market (2025)
€189 B
EU HealthTech market (2025)
950+
FDA AI/ML devices cleared
6
Solutions featured

Market snapshot

Where the US and EU are investing — and the regulations driving transformation.

United States

$394 Bat 17.8 % CAGR
  • FHIR interoperability (USCDI v3 mandate)
  • AI clinical decision support (950+ FDA devices)
  • Cybersecurity (updated HIPAA Security Rule)
  • Value-based care and population health

European Union

€189 Bat 15.2 % CAGR
  • EHDS implementation (cross-border by 2029)
  • EU AI Act for medical devices
  • Digital therapeutics frameworks (DiGA model)
  • NIS2 healthcare cybersecurity obligations

Trending solutions

Six high-impact HealthTech solutions that US and EU providers, payers, and regulators are prioritizing — with market context and what we deliver.

USEU

AI Clinical Decision Support

Evidence-based recommendations at the point of care

82
Market
readiness

AI-powered CDS systems analyze patient data in real time — flagging drug interactions, suggesting diagnoses, and prioritizing care pathways. Hospitals using AI CDS report 30 % fewer diagnostic errors and 22 % shorter time-to-treatment for critical conditions.

United States

FDA has cleared 950+ AI/ML-enabled medical devices (as of Jan 2026). ONC's HTI-1 rule requires certified EHRs to support clinical decision support interventions. CMS value-based care programs incentivize AI-driven quality improvement.

European Union

The EU MDR classifies clinical AI software as medical devices requiring CE marking. The EU AI Act designates medical AI as high-risk — requiring conformity assessments, human oversight, and post-market surveillance. EMA's reflections on AI emphasize transparency in algorithmic medicine.

950+
FDA-cleared AI devices
30 %
Diagnostic error reduction
22 %
Time-to-treatment reduction

What we deliver

Real-time clinical alerts in EHR workflows
Differential diagnosis suggestion engines
Drug interaction and allergy checking (RxNorm/SNOMED)
Radiology and pathology AI integration
FDA 510(k) / EU MDR / AI Act compliance support
USEU

Remote Patient Monitoring (RPM)

Continuous care beyond hospital walls

88
Market
readiness

RPM platforms connect wearable devices and home monitors to clinical teams — enabling early intervention for chronic conditions, reducing hospital readmissions by 38 %, and improving patient satisfaction scores by 45 %.

United States

CMS expanded RPM reimbursement codes (CPT 99453–99458) in 2024 — 43 % of US health systems now offer RPM programs. The 2024–2030 Federal Health IT Strategic Plan prioritizes 'care anywhere' infrastructure. RPM is projected to reach $117 B in the US by 2027.

European Union

The EHDS enables cross-border sharing of RPM data. The European Commission's 2024 Digital Health Strategy calls for scaling telehealth and remote monitoring. Germany's DiGA framework has approved 60+ digital health apps for prescribing.

43 %
US health systems with RPM
38 %
Readmission reduction
60+
EU DiGA apps approved

What we deliver

IoT/wearable integration platform (BLE, FHIR)
Real-time vitals dashboards for care teams
AI-driven anomaly detection and alerts
Patient-facing mobile apps with engagement tools
CMS RPM billing support and DiGA compliance
USEU

Digital Therapeutics (DTx)

Evidence-based software as medicine

72
Market
readiness

DTx products deliver clinically validated therapeutic interventions through software — treating conditions from diabetes and insomnia to substance use disorder and ADHD. The market is growing at 26 % CAGR as regulatory pathways mature and payer reimbursement expands.

United States

FDA's Digital Health Center of Excellence has a dedicated De Novo/510(k) pathway for DTx. Pear Therapeutics' reSET-O and Akili's EndeavorRx set precedents for prescription digital therapeutics. 28 % of US payers now cover at least one DTx product.

European Union

Germany leads globally with its DiGA (Digitale Gesundheitsanwendungen) fast-track — 60+ DTx apps available on prescription with statutory health insurance coverage. France (PECAN), Belgium, and Sweden follow with national DTx frameworks.

26 %
Global DTx CAGR
28 %
US payer coverage
60+ apps
Germany DiGA fast-track

What we deliver

DTx application development (iOS/Android/Web)
Randomized clinical trial design support
FDA De Novo / CE-MDR / DiGA regulatory strategy
Payer evidence generation and HEOR analysis
EHR integration for prescribing workflows
USEU

FHIR-First Interoperability

HL7 FHIR R4 / USCDI / EHDS — seamless health data exchange

93
Market
readiness

Interoperability is no longer optional. FHIR-based APIs are the standard for health data exchange — mandated by US regulation and foundational to the EU EHDS. We build FHIR-native systems that connect EHRs, patient portals, and public health registries.

United States

ONC's HTI-1 Final Rule mandates USCDI v3 (effective Jan 2026) and FHIR R4 APIs for certified health IT. CMS Interoperability rules require payers to expose member data via Patient Access APIs. 96 % of US hospitals now have FHIR-capable EHRs.

European Union

The EHDS Regulation (EU 2025/327) establishes FHIR-based European EHR Exchange Format (EEHRxF) for cross-border data sharing. Priority categories (patient summaries, ePrescriptions, lab results, medical images) must be interoperable by March 2029.

96 %
US hospitals FHIR-ready
Jan 2026
USCDI v3 mandate
Mar 2029
EHDS cross-border deadline

What we deliver

FHIR R4 server and API development
USCDI v3 / EEHRxF mapping and validation
SMART on FHIR application framework
Bulk FHIR for population health and research
Cross-border MyHealth@EU integration support
USEU

Healthcare Cybersecurity

Protecting patient data and clinical operations

86
Market
readiness

Healthcare is the costliest sector for data breaches — $10.93 M average per incident (IBM 2025). Ransomware attacks on hospitals doubled in 2024. We deliver defense-in-depth security designed for the unique challenges of clinical environments.

United States

HHS updated the HIPAA Security Rule in 2025 with mandatory MFA, encryption at rest, and 72-hour incident reporting. CISA's Healthcare Cybersecurity Performance Goals (CPGs) guide hospitals on minimum security controls. 86 % of health systems increased cyber budgets in FY 2025.

European Union

NIS2 Directive extends cybersecurity obligations to healthcare entities from Oct 2024. The EHDS requires security measures for health data processing. ENISA's healthcare cybersecurity guidelines emphasize supply-chain risk management and incident response.

$10.93 M
Avg. breach cost
86 %
US cyber budget increase
27 states
NIS2 healthcare coverage

What we deliver

Medical device security assessment (MDS2)
HIPAA Security Rule / NIS2 compliance implementation
Zero-trust architecture for clinical networks
Security Operations Center (SOC) as a service
Ransomware resilience and incident response planning
USEU

Population Health & Analytics

Data-driven insights for public health and value-based care

80
Market
readiness

Population health platforms aggregate clinical, claims, and social determinants data to identify at-risk cohorts, optimize care pathways, and demonstrate outcomes for value-based contracts. Health systems using advanced analytics see 18–25 % improvements in quality metrics.

United States

CMS's ACO REACH and MSSP programs cover 13 M+ beneficiaries in value-based arrangements. USCDI v3 includes SDOH data elements (housing, food security). CDC's Data Modernization Initiative invested $1 B+ in public health data infrastructure.

European Union

EHDS secondary use provisions enable anonymized data for research, policy, and public health surveillance. The European Health Data Space is expected to unlock €5.4 B in health data value by 2030. EU Beating Cancer Plan leverages population-level data for screening optimization.

13 M+
US VBC beneficiaries
+25 %
Quality metric improvement
€5.4 B
EU EHDS data value (2030)

What we deliver

Population health data warehouse and lake
Risk stratification and predictive modeling
SDOH data integration and community resource mapping
Quality measure dashboards (HEDIS, eCQMs)
EHDS secondary use and research data platforms

Why health systems choose us

Compliance-native

HIPAA, GDPR, EHDS, MDR, EU AI Act — compliance is embedded in every design decision, not an afterthought.

Clinical context

Our teams include clinical informaticists who understand EHR workflows, care pathways, and the realities of clinical adoption.

Regulatory strategy

From FDA 510(k) to DiGA fast-track to CE marking — we help you navigate the regulatory pathway alongside development.

Ready to build next-gen health IT?

Tell us your clinical and regulatory requirements — we'll scope a HIPAA/EHDS-compliant solution aligned to your care delivery model.